Investing Profile

Clay Thorp

InvestorVC

General Partner at Hatteras Venture Partners

hatterasvp.comChapel Hill, North Carolina
Photo of Clay Thorp, General Partner at Hatteras Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
10
$94M
CompanyStageDateRound SizeTotal Raised
Rodin Therapeutics
Series CSep 2017$27M
$57M
Co-investors: Ben Robbins (GV), Bruce Booth (Atlas Venture)
Lysosomal Therapeutics
Series AFeb 2015$20M
Seed RoundMay 2014$4.8M
$25M
Co-investors: Bernard Davitian (Omega Funds), Bruce Booth (Atlas Venture), Carole Nuechterlein (Roche Venture Fund)
Clearside Biomedical
Series BSep 2014$16M
Series AFeb 2013$7.9M
Series AJan 2012$4M
$28M
Co-investors: Christy Shaffer (Hatteras Venture Partners)
Curoverse
Seed RoundDec 2013$1.5M
$1.5M
Co-investors: David Martirano (Point Judith Capital), Jennifer Jordan (iGlobe Partners)
Pathfinder Therapeutics
Series AOct 2008$5M
$5M
ArtusLabs
Series AJun 2008$2.6M
$2.6M
Empliant
Venture RoundJul 2001$500K
$500K